Freeline Therapeutics Holdings plc announced the appointment of Colin A. Love, PhD, to its Board of Directors with immediate effect. Dr. Love has over 30 years of experience leading biopharmaceutical company operations, including the development and launch of several biotechnology products. Dr. Love brings more than three decades of experience developing, manufacturing and launching biotechnology products. He currently is the Chief Operating Officer and a co-founder of Replimune, a biotechnology company developing oncolytic immunotherapies, where he has served since 2015. Since December 2014, he has provided consultancy support to a range of life science companies, from small gene therapy start-ups to large established biotechnology companies, including Amgen.